位置:首页 > 蛋白库 > CASP6_CHICK
CASP6_CHICK
ID   CASP6_CHICK             Reviewed;         304 AA.
AC   A0A1D5PPP7; O93415;
DT   23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT   10-APR-2019, sequence version 2.
DT   03-AUG-2022, entry version 27.
DE   RecName: Full=Caspase-6 {ECO:0000303|PubMed:10684799};
DE            Short=CASP-6;
DE            EC=3.4.22.59 {ECO:0000250|UniProtKB:P55212};
DE   Contains:
DE     RecName: Full=Caspase-6 subunit p18 {ECO:0000250|UniProtKB:P55212};
DE   Contains:
DE     RecName: Full=Caspase-6 subunit p11 {ECO:0000250|UniProtKB:P55212};
GN   Name=CASP6 {ECO:0000250|UniProtKB:P55212};
OS   Gallus gallus (Chicken).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda;
OC   Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae;
OC   Phasianinae; Gallus.
OX   NCBI_TaxID=9031;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=10684799; DOI=10.1095/biolreprod62.3.589;
RA   Johnson A.L., Bridgham J.T.;
RT   "Caspase-3 and -6 expression and enzyme activity in hen granulosa cells.";
RL   Biol. Reprod. 62:589-598(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RX   PubMed=11953316; DOI=10.1093/emboj/21.8.1967;
RA   Ruchaud S., Korfali N., Villa P., Kottke T.J., Dingwall C., Kaufmann S.H.,
RA   Earnshaw W.C.;
RT   "Caspase-6 gene disruption reveals a requirement for lamin A cleavage in
RT   apoptotic chromatin condensation.";
RL   EMBO J. 21:1967-1977(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Red jungle fowl;
RX   PubMed=15592404; DOI=10.1038/nature03154;
RA   Hillier L.W., Miller W., Birney E., Warren W., Hardison R.C., Ponting C.P.,
RA   Bork P., Burt D.W., Groenen M.A.M., Delany M.E., Dodgson J.B.,
RA   Chinwalla A.T., Cliften P.F., Clifton S.W., Delehaunty K.D., Fronick C.,
RA   Fulton R.S., Graves T.A., Kremitzki C., Layman D., Magrini V.,
RA   McPherson J.D., Miner T.L., Minx P., Nash W.E., Nhan M.N., Nelson J.O.,
RA   Oddy L.G., Pohl C.S., Randall-Maher J., Smith S.M., Wallis J.W.,
RA   Yang S.-P., Romanov M.N., Rondelli C.M., Paton B., Smith J., Morrice D.,
RA   Daniels L., Tempest H.G., Robertson L., Masabanda J.S., Griffin D.K.,
RA   Vignal A., Fillon V., Jacobbson L., Kerje S., Andersson L.,
RA   Crooijmans R.P., Aerts J., van der Poel J.J., Ellegren H., Caldwell R.B.,
RA   Hubbard S.J., Grafham D.V., Kierzek A.M., McLaren S.R., Overton I.M.,
RA   Arakawa H., Beattie K.J., Bezzubov Y., Boardman P.E., Bonfield J.K.,
RA   Croning M.D.R., Davies R.M., Francis M.D., Humphray S.J., Scott C.E.,
RA   Taylor R.G., Tickle C., Brown W.R.A., Rogers J., Buerstedde J.-M.,
RA   Wilson S.A., Stubbs L., Ovcharenko I., Gordon L., Lucas S., Miller M.M.,
RA   Inoko H., Shiina T., Kaufman J., Salomonsen J., Skjoedt K., Wong G.K.-S.,
RA   Wang J., Liu B., Wang J., Yu J., Yang H., Nefedov M., Koriabine M.,
RA   Dejong P.J., Goodstadt L., Webber C., Dickens N.J., Letunic I., Suyama M.,
RA   Torrents D., von Mering C., Zdobnov E.M., Makova K., Nekrutenko A.,
RA   Elnitski L., Eswara P., King D.C., Yang S.-P., Tyekucheva S.,
RA   Radakrishnan A., Harris R.S., Chiaromonte F., Taylor J., He J.,
RA   Rijnkels M., Griffiths-Jones S., Ureta-Vidal A., Hoffman M.M., Severin J.,
RA   Searle S.M.J., Law A.S., Speed D., Waddington D., Cheng Z., Tuzun E.,
RA   Eichler E., Bao Z., Flicek P., Shteynberg D.D., Brent M.R., Bye J.M.,
RA   Huckle E.J., Chatterji S., Dewey C., Pachter L., Kouranov A.,
RA   Mourelatos Z., Hatzigeorgiou A.G., Paterson A.H., Ivarie R., Brandstrom M.,
RA   Axelsson E., Backstrom N., Berlin S., Webster M.T., Pourquie O.,
RA   Reymond A., Ucla C., Antonarakis S.E., Long M., Emerson J.J., Betran E.,
RA   Dupanloup I., Kaessmann H., Hinrichs A.S., Bejerano G., Furey T.S.,
RA   Harte R.A., Raney B., Siepel A., Kent W.J., Haussler D., Eyras E.,
RA   Castelo R., Abril J.F., Castellano S., Camara F., Parra G., Guigo R.,
RA   Bourque G., Tesler G., Pevzner P.A., Smit A., Fulton L.A., Mardis E.R.,
RA   Wilson R.K.;
RT   "Sequence and comparative analysis of the chicken genome provide unique
RT   perspectives on vertebrate evolution.";
RL   Nature 432:695-716(2004).
CC   -!- FUNCTION: Cysteine protease that plays essential roles in programmed
CC       cell death, development and innate immunity (PubMed:11953316). Acts as
CC       a non-canonical executioner caspase during apoptosis: localizes in the
CC       nucleus and cleaves the nuclear structural protein lamin-A/LMNA thereby
CC       inducing nuclear shrinkage and fragmentation (PubMed:11953316). Lamin-
CC       A/LMNA cleavage is required for chromatin condensation and nuclear
CC       disassembly during apoptotic execution (PubMed:11953316). Plays an
CC       essential role in defense against viruses by acting as a central
CC       mediator of the ZBP1-mediated pyroptosis, apoptosis, and necroptosis
CC       (PANoptosis), independently of its cysteine protease activity.
CC       PANoptosis is a unique inflammatory programmed cell death, which
CC       provides a molecular scaffold that allows the interactions and
CC       activation of machinery required for inflammasome/pyroptosis, apoptosis
CC       and necroptosis (By similarity). {ECO:0000250|UniProtKB:P55212,
CC       ECO:0000269|PubMed:11953316}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Strict requirement for Asp at position P1 and has a preferred
CC         cleavage sequence of Val-Glu-His-Asp-|-.; EC=3.4.22.59;
CC         Evidence={ECO:0000250|UniProtKB:P55212};
CC   -!- ACTIVITY REGULATION: During activation, the N-terminal prodomain is
CC       removed by cleavage (By similarity). Concomitantly, double cleavage
CC       gives rise to a large 18-kDa and a small 11-kDa subunit (By
CC       similarity). The two large and two small subunits then assemble to form
CC       the active CASP6 complex (By similarity). Intramolecular cleavage at
CC       Asp-191 is a prerequisite for CASP6 self-activation (By similarity).
CC       {ECO:0000250|UniProtKB:P55212}.
CC   -!- SUBUNIT: Heterotetramer that consists of two anti-parallel arranged
CC       heterodimers, each one formed by a 18 kDa (p18) and a 11 kDa (p11)
CC       subunit. {ECO:0000250|UniProtKB:P55212}.
CC   -!- SUBUNIT: [Caspase-6 subunit p18]: Heterotetramer that consists of two
CC       anti-parallel arranged heterodimers, each one formed by a 18 kDa
CC       (Caspase-6 subunit p18) and a 11 kDa (Caspase-6 subunit p11) subunit.
CC       {ECO:0000250|UniProtKB:P55212}.
CC   -!- SUBUNIT: [Caspase-6 subunit p11]: Heterotetramer that consists of two
CC       anti-parallel arranged heterodimers, each one formed by a 18 kDa
CC       (Caspase-6 subunit p18) and a 11 kDa (Caspase-6 subunit p11) subunit.
CC       {ECO:0000250|UniProtKB:P55212}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P55212}. Nucleus
CC       {ECO:0000250|UniProtKB:P55212}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:10684799}.
CC   -!- DOMAIN: The N-terminal disordered prodomain is required to prevent
CC       self-activation. {ECO:0000250|UniProtKB:P55212}.
CC   -!- DOMAIN: The Tri-arginine exosite is required to recruit substrates for
CC       hydrolysis. {ECO:0000250|UniProtKB:P55212}.
CC   -!- DOMAIN: Undergoes helix-strand structural transitions upon substrate-
CC       binding: the 130's region interconverts between an inactive helical
CC       state and the canonically active strand state. Other caspases rest
CC       constitutively in the strand conformation before and after substrate-
CC       binding. {ECO:0000250|UniProtKB:P55212}.
CC   -!- SIMILARITY: Belongs to the peptidase C14A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF082329; AAC32378.1; -; mRNA.
DR   EMBL; AF469049; AAL82386.1; -; Genomic_DNA.
DR   EMBL; AADN05000017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_990057.1; NM_204726.1.
DR   MEROPS; C14.005; -.
DR   Ensembl; ENSGALT00000057584; ENSGALP00000054851; ENSGALG00000012186.
DR   GeneID; 395477; -.
DR   KEGG; gga:395477; -.
DR   CTD; 839; -.
DR   VEuPathDB; HostDB:geneid_395477; -.
DR   GeneTree; ENSGT00940000155140; -.
DR   OrthoDB; 984395at2759; -.
DR   Proteomes; UP000000539; Chromosome 4.
DR   Bgee; ENSGALG00000012186; Expressed in kidney and 13 other tissues.
DR   ExpressionAtlas; A0A1D5PPP7; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IMP:AgBase.
DR   GO; GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:0097200; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; IEA:InterPro.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IDA:AgBase.
DR   GO; GO:0002218; P:activation of innate immune response; ISS:UniProtKB.
DR   GO; GO:0030263; P:apoptotic chromosome condensation; IGI:AgBase.
DR   GO; GO:0006309; P:apoptotic DNA fragmentation; IGI:AgBase.
DR   GO; GO:0030262; P:apoptotic nuclear changes; IGI:AgBase.
DR   GO; GO:0006915; P:apoptotic process; IMP:AgBase.
DR   GO; GO:0097284; P:hepatocyte apoptotic process; ISS:UniProtKB.
DR   GO; GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; ISS:UniProtKB.
DR   GO; GO:0070306; P:lens fiber cell differentiation; TAS:AgBase.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0060545; P:positive regulation of necroptotic process; ISS:UniProtKB.
DR   GO; GO:0016540; P:protein autoprocessing; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IGI:AgBase.
DR   GO; GO:0070269; P:pyroptosis; ISS:UniProtKB.
DR   CDD; cd00032; CASc; 1.
DR   InterPro; IPR029030; Caspase-like_dom_sf.
DR   InterPro; IPR037554; Caspase_6.
DR   InterPro; IPR033139; Caspase_cys_AS.
DR   InterPro; IPR002398; Pept_C14.
DR   InterPro; IPR002138; Pept_C14_p10.
DR   InterPro; IPR001309; Pept_C14_p20.
DR   InterPro; IPR015917; Pept_C14A.
DR   PANTHER; PTHR10454; PTHR10454; 1.
DR   PANTHER; PTHR10454:SF206; PTHR10454:SF206; 1.
DR   PRINTS; PR00376; IL1BCENZYME.
DR   SMART; SM00115; CASc; 1.
DR   SUPFAM; SSF52129; SSF52129; 1.
DR   PROSITE; PS01122; CASPASE_CYS; 1.
DR   PROSITE; PS50207; CASPASE_P10; 1.
DR   PROSITE; PS50208; CASPASE_P20; 1.
PE   2: Evidence at transcript level;
KW   Apoptosis; Autocatalytic cleavage; Cytoplasm; Hydrolase; Nucleus; Protease;
KW   Reference proteome; Thiol protease; Zymogen.
FT   CHAIN           1..304
FT                   /note="Caspase-6"
FT                   /id="PRO_0000454577"
FT   PROPEP          1..35
FT                   /evidence="ECO:0000303|PubMed:10684799"
FT                   /id="PRO_0000454578"
FT   CHAIN           36..191
FT                   /note="Caspase-6 subunit p18"
FT                   /evidence="ECO:0000250|UniProtKB:P55212"
FT                   /id="PRO_0000454579"
FT   PROPEP          192..204
FT                   /evidence="ECO:0000250|UniProtKB:P55212"
FT                   /id="PRO_0000454580"
FT   CHAIN           205..304
FT                   /note="Caspase-6 subunit p11"
FT                   /evidence="ECO:0000250|UniProtKB:P55212"
FT                   /id="PRO_0000454581"
FT   REGION          1..29
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          54..56
FT                   /note="Tri-arginine exosite"
FT                   /evidence="ECO:0000250|UniProtKB:P55212"
FT   REGION          137..154
FT                   /note="130's region"
FT                   /evidence="ECO:0000250|UniProtKB:P55212"
FT   ACT_SITE        133
FT                   /evidence="ECO:0000250|UniProtKB:P55212"
FT   ACT_SITE        175
FT                   /evidence="ECO:0000250|UniProtKB:P55212"
FT   CONFLICT        41
FT                   /note="Q -> R (in Ref. 1; AAC32378 and 2; AAL82386)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        47
FT                   /note="V -> E (in Ref. 1; AAC32378 and 2; AAL82386)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   304 AA;  34476 MW;  AEFB3B7A68303C83 CRC64;
     MSGAERRPAA GRVQLDSKPT PTTTADGNQN ITEVDAFDKR QTFDPAVQYK MNHQRRGVAL
     IFNHEHFFWH LRLPDRRGTL ADRNNLKRSL TDLGFEVRIF DDLKAEDVLK KVFEASRDDY
     SNADCFVCVF LSHGENDHVY AYDAQIKIET ITNMFRGDKC QSLVGKPKIF IIQACRGDKH
     DDPVLVQDSV DSKDETTVNQ TEVDAAGVYT LPAGADFIMC YSVAQGYFSH RETVNGSWYI
     QDLCEALGKH GSSLEFTELL TVVNRKVSHR KVDICRDINA IGKKQIPCFA SMLTKKLYFH
     PKSK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024